243: George Scangos' retirement, annual Covid vaccines, an Alzheimer's drug rejection
George Scangos, the CEO of Vir Biotechnology, joins us to discuss his retirement and offer some perspective and lessons from a remarkable, 40-year career in biotech. We also chat about the latest news in the life sciences, including an FDA advisory meeting debating the necessity for annual Covid vaccinations, and a surprising, but perhaps not, rejection of Eli Lilly\u2019s Alzheimer\u2019s disease treatment.